头孢匹胺的体外抗菌活性。
In vitro antibacterial activity of cefpiramide.
作者信息
Pfaller M A, Niles A C, Murray P R
出版信息
Antimicrob Agents Chemother. 1984 Mar;25(3):368-72. doi: 10.1128/AAC.25.3.368.
Abstract
A microbroth dilution method was used to measure the MICs of cefpiramide (SM 1652), cefotaxime, moxalactam, ceftazidime, cefoperazone, ceftriaxone, piperacillin, and mezlocillin against 921 isolates of gram-negative (701) and gram-positive (220) bacteria. The activity of cefpiramide was equivalent to those of piperacillin and mezlocillin against members of the family Enterobacteriaceae and gram-positive isolates, including enterococci. Cefpiramide had equivalent or slightly greater activity against Pseudomonas aeruginosa than the other beta-lactam antibiotics tested.
摘要
采用微量肉汤稀释法测定头孢匹胺（SM 1652）、头孢噻肟、拉氧头孢、头孢他啶、头孢哌酮、头孢曲松、哌拉西林和美洛西林对921株革兰氏阴性菌（701株）和革兰氏阳性菌（220株）的最低抑菌浓度（MIC）。头孢匹胺对肠杆菌科细菌和革兰氏阳性菌（包括肠球菌）的活性与哌拉西林和美洛西林相当。头孢匹胺对铜绿假单胞菌的活性与其他受试β-内酰胺类抗生素相当或略强。
相似文献
1
In vitro antibacterial activity of cefpiramide.头孢匹胺的体外抗菌活性。
Antimicrob Agents Chemother. 1984 Mar;25(3):368-72. doi: 10.1128/AAC.25.3.368.
2
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.羟羧氧酰胺菌素、头孢噻肟、头孢哌酮、哌拉西林和氨基糖苷类药物对革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1980 Oct;18(4):645-8. doi: 10.1128/AAC.18.4.645.
3
Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.头孢匹胺和阿帕西林单独及联合使用时的体外比较活性
Antimicrob Agents Chemother. 1985 May;27(5):782-90. doi: 10.1128/AAC.27.5.782.
4
In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.用改良琼脂稀释法检测头孢他啶、头孢噻肟和哌拉西林对多重耐药革兰氏阴性菌的体外活性。
Eur J Clin Microbiol. 1982 Jun;1(3):166-70. doi: 10.1007/BF02019618.
5
The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics.头孢匹胺与其他β-内酰胺类抗生素相比的体外活性及β-内酰胺酶稳定性。
Diagn Microbiol Infect Dis. 1985 Nov;3(6):479-88. doi: 10.1016/s0732-8893(85)80004-3.
6
An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.新型头孢菌素的体外比较，特别涉及铜绿假单胞菌。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:97-105. doi: 10.1093/jac/8.suppl_b.97.
7
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.新型β-内酰胺类抗生素对囊性纤维化患者铜绿假单胞菌分离株的活性。
Antimicrob Agents Chemother. 1981 Oct;20(4):545-6. doi: 10.1128/AAC.20.4.545.
8
In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.头孢匹胺及其他广谱抗生素对中国440株临床分离菌的体外抗菌活性
J Infect Chemother. 2000 Jun;6(2):81-5. doi: 10.1007/pl00012156.
9
The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Acta Pathol Microbiol Immunol Scand B. 1982 Feb;90(1):69-72. doi: 10.1111/j.1699-0463.1982.tb00082.x.
10
In vitro activity of BRL 36650, a new penicillin.新型青霉素BRL 36650的体外活性
Antimicrob Agents Chemother. 1986 Feb;29(2):362-6. doi: 10.1128/AAC.29.2.362.
引用本文的文献
1
Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins.将BMY-28142、头孢布宗和头孢匹胺的抗菌活性与其他头孢菌素的抗菌活性进行比较。
Antimicrob Agents Chemother. 1984 Oct;26(4):585-90. doi: 10.1128/AAC.26.4.585.
2
Pharmacokinetics and bacteriological efficacies of apalcillin and cefpiramide in experimental pneumococcal meningitis.阿帕西林和头孢匹胺在实验性肺炎球菌脑膜炎中的药代动力学及细菌学疗效
Antimicrob Agents Chemother. 1984 Oct;26(4):578-9. doi: 10.1128/AAC.26.4.578.
3
Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.头孢匹胺纸片药敏试验的解释标准和质量控制指南。
J Clin Microbiol. 1985 Oct;22(4):688-90. doi: 10.1128/jcm.22.4.688-690.1985.
4
Respiratory superinfections after the use of third-generation cephem antibiotics.
Infection. 1985;13 Suppl 1:S89-95. doi: 10.1007/BF01644226.
5
Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.头孢匹胺和阿帕西林单独及联合使用时的体外比较活性
Antimicrob Agents Chemother. 1985 May;27(5):782-90. doi: 10.1128/AAC.27.5.782.
6
High hepatic excretion in humans of cefpiramide, a new cephalosporin.新型头孢菌素头孢匹胺在人体内的高肝脏排泄率。
Antimicrob Agents Chemother. 1988 Sep;32(9):1360-4. doi: 10.1128/AAC.32.9.1360.
7
Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin.
Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):544-9. doi: 10.1007/BF01962612.
本文引用的文献
1
Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.与其他广谱头孢菌素相比，SM-1652的抗菌活性。
Antimicrob Agents Chemother. 1982 Nov;22(5):721-7. doi: 10.1128/AAC.22.5.721.
2
In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.具有抗假单胞菌活性的新型广谱头孢菌素SM-1652的体外抗菌活性
Antimicrob Agents Chemother. 1983 Feb;23(2):195-200. doi: 10.1128/AAC.23.2.195.
Zotero 插件